Previous 10 | Next 10 |
MOUNTAIN VIEW, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended September 28, 2019. Third Quarter Highlights Total revenue of $10.7 million Cyclo G6® product family revenue of $3.0 million...
MOUNTAIN VIEW, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Stifel Healthcare Conference in New York City. David I. Bruce, IRIDEX’s President and Chief Executive Officer, is scheduled t...
MOUNTAIN VIEW, Calif., Oct. 28, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the appointment of Robert Gunst as Chairman of the Board, effective October 23, 2019. Concurrent with this appointment, Ruediger Naumann-Etienne departed from the Board of Directors as...
MOUNTAIN VIEW, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the third quarter of 2019 after the close of trading on Thursday, November 7, 2019. The Company’s management team will host ...
Gainers: Interlink Electronics ( OTCPK:LINK ) +37% . Avadel Pharmaceuticals plc (NASDAQ: AVDL ) +33% . Arotech Corporation (NASDAQ: ARTX ) +31% . Plus Therapeutics (NASDAQ: PSTV ) +25% . Cesca Therapeutics (NASDAQ: KOOL ) +20% . PriceSmart (NASDAQ: PSMT ) +18% . Dova Pharmaceuticals...
MOUNTAIN VIEW, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that its patented MicroPulse® laser therapy will be featured...
IRIDEX Corp (IRIX) Q2 2019 Earnings Conference Call Aug 6, 2019 5:00 PM ET Company Participants Leigh Salvo - Head, Investor Relations David Bruce - President and Chief Executive Officer Romeo Dizon - Vice President of Finance Conference Call Participants Trevor Brown - Sti...
IRIDEX (NASDAQ: IRIX ): Q2 GAAP EPS of -$0.18 beats by $0.04 . More news on: IRIDEX Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...
MOUNTAIN VIEW, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended June 29, 2019. Second Quarter Highlights Total revenue of $10.4 million ○ Cyclo G6 product family revenue of $3.4 mi...
MOUNTAIN VIEW, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter of 2019 after the close of trading on Tuesday, August 6, 2019. The Company’s management team will host a ...
News, Short Squeeze, Breakout and More Instantly...
MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the Company...